Nieuws en video's - CRYOPORT INC. - Pagina 3

Cryoport Reports Results for the Second Quarter 2022 PR Newswire NASHVILLE, Tenn., Aug. 4, 2022 Record revenue of $64.2 million for the quarter, up 14% as reported and 18% at constant currency (year-over-year) Supporting a record 626 global clinical trials; a net of 17 new trials added during the quarter Opened first two Global Supply Chain Centers, which include BioServices, in June 2022 Expanded global footprint into Spain and Ireland NASHVILLE, Tenn. , Aug. 4, 2022 /PRNewswire/ -- Cryoport,...

Cryoport to Report Second Quarter 2022 Financial Results on August 4, 2022 PR Newswire NASHVILLE, Tenn., July 28, 2022 NASHVILLE, Tenn. , July 28, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the three months period ended June 30, 2022 (second quarter 2022) on Thursday, August 4, 2022 after U.S....

Cryoport Reports First Quarter 2022 Results PR Newswire NASHVILLE, Tenn., May 5, 2022 Revenue of $52.3 million Provides Full Year 2022 Revenue Guidance of $260 - $265 million Expansion and advancement of robust clinical pipeline continues – now supporting a record 609 clinical trials, with Phase 3 clinical trials increasing from 69 to 81 year over year Cash and short-term investments of $600 million NASHVILLE, Tenn. , May 5, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the...

Cryoport to Report First Quarter 2022 Financial Results on May 5, 2022 PR Newswire NASHVILLE, Tenn., April 28, 2022 NASHVILLE, Tenn. , April 28, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the three months period ended March 31, 2022 (first quarter 2022) on Thursday, May 5, 2022 after U.S. markets...

Cryoport Acquires Cell&Co BioServices PR Newswire NASHVILLE, Tenn., April 18, 2022 Acquisition of Cell&Co BioServices, Clermont-Ferrand , France, accelerates Company's EMEA expansion plans and development of its Global Supply Chain Network NASHVILLE, Tenn. , April 18, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that it has acquired Cell&Co...

Cryoport's MVE Biological Solutions' New Prague Manufacturing Plant Returns to Full Production PR Newswire NASHVILLE, Tenn., March 30, 2022 Company provides further update on financial impact of New Prague, MN fire NASHVILLE, Tenn. , March 30, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that its New Prague facility has returned to full production....

Cryoport Authorizes $100 Million Repurchase Program PR Newswire NASHVILLE, Tenn., March 11, 2022 Management Presenting at Upcoming Investor Conferences NASHVILLE, Tenn. , March 11, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced its Board of Directors has unanimously authorized a repurchase program, under which Cryoport may repurchase up to $100...

Cryoport Reports Fourth Quarter and Full Year 2021 Results - 2021 annual revenue grew to $222.6 million, representing 183% year-over-year growth - Cryoport Systems and CRYOGENE revenue grew 34% year-over-year for the fourth quarter - Enters 2022 with $629 million in cash and short-term investments - Expansion and advancement of robust clinical pipeline continues - now supporting a record 602 clinical trials with 273 in Phase 2 and 74 in Phase 3 PR Newswire NASHVILLE, Tenn., Feb. 24, 2022...

Cryoport Report's Fourth Quarter and 2021 Financial Results on February 24, 2022 PR Newswire NASHVILLE, Tenn., Feb. 15, 2022 NASHVILLE, Tenn. , Feb. 15, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the fourth quarter and year ended December 31, 2021 on Thursday, February 24, 2022 after U.S. markets...

Cryoport Provides Positive Update on MVE Biological Solution's New Prague Facility Production Expected to Resume Week of February 14, 2022 PR Newswire NASHVILLE, Tenn., Feb. 9, 2022 NASHVILLE, Tenn. , Feb. 9, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today provided an update on resumption of activities at the New Prague facility. As previously announced, a fire...

Cryoport Reports Fire Damage at MVE's New Prague Facility PR Newswire NASHVILLE, Tenn., Jan. 31, 2022 NASHVILLE, Tenn. , Jan. 31, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today reports that on January 25, 2022 , a fire occurred at the MVE Biological Solutions manufacturing facility located in New Prague, Minnesota . The New Prague facility manufactures...

Cryoport and Cell Matters Enter into Strategic Partnership Further Strengthening Capabilities in the EMEA Region PR Newswire NASHVILLE, Tenn., Jan. 27, 2022 NASHVILLE, Tenn. , Jan. 27, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that it has entered into a strategic partnership with Cell Matters, S.A. to deliver to the life sciences industry...

Cryoport to Present at the J.P. Morgan 40th Annual Healthcare Conference PR Newswire NASHVILLE, Tenn., Jan. 5, 2022 NASHVILLE, Tenn. , Jan. 5, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that Jerrell Shelton , the Company's Chief Executive Officer and Robert Stefanovich , the Company's Chief Financial Officer will be presenting at the J.P. Morgan...

Cryoport, Inc. Prices Registered Direct Placement of Common Stock PR Newswire NASHVILLE, Tenn., Nov. 9, 2021 NASHVILLE, Tenn. , Nov. 9, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the pricing of its registered direct placement of 3,072,038 shares of common stock, at a price of $81.10 per share, in a direct placement registered under the Securities Act of 1933, as amended. The...

Cryoport, Inc. Prices Upsized $350.0 Million Convertible Senior Notes Offering PR Newswire NASHVILLE, Tenn., Nov. 9, 2021 NASHVILLE, Tenn. , Nov. 9, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the pricing of its offering of $350,000,000 aggregate principal amount of 0.75% convertible senior notes due 2026 (the "notes") in a private offering to qualified institutional buyers...

Cryoport, Inc. Announces Proposed Convertible Senior Notes Offering PR Newswire NASHVILLE, Tenn., Nov. 8, 2021 NASHVILLE, Tenn. , Nov. 8, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced its intention to offer, subject to market and other conditions, $300,000,000 aggregate principal amount of convertible senior notes due 2026 (the "notes") in a private offering to qualified...

Cryoport, Inc. Announces Proposed Registered Direct Placement of Common Stock PR Newswire NASHVILLE, Tenn., Nov. 8, 2021 NASHVILLE, Tenn. , Nov. 8, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced its intention to offer, subject to market and other conditions, shares of its common stock in a direct placement registered under the Securities Act of 1933, as amended. The number of...

Cryoport Reports Record Third Quarter and Nine Months Revenue for 2021 - Third quarter revenue increased 407% year over year, reaching $56.7 million; Nine Months 2021 revenue $166.2 million - Organic Revenue Growth of 38% coupled with continuing strong performance by MVE Biological Solutions and CRYOPDP - Now supporting a record 582 clinical trials and eight commercial therapies in regenerative medicine PR Newswire NASHVILLE, Tenn., Nov. 4, 2021 NASHVILLE, Tenn. , Nov. 4, 2021 /PRNewswire/ --...

CRYOPDP, a Cryoport Company, Receives 2021 Europe Bioprocessing Excellence Award from IMAPAC CRYOPDP, a Cryoport Company, named as 'The Company You Need to Watch Out For in 2022' PR Newswire NASHVILLE, Tenn., Oct. 29, 2021 NASHVILLE, Tenn. , Oct. 29, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that its wholly-owned operating company, CRYOPDP , a...

Cryoport to Report Third Quarter 2021 Financial Results on November 4, 2021 PR Newswire NASHVILLE, Tenn., Oct. 28, 2021 NASHVILLE, Tenn. , Oct. 28, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the third quarter ended September 30, 2021 on Thursday, November 4, 2021 after U.S. markets close. In...